Ingenito; Raffaele

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ingenito; Raffaele.The latest application filed is for "modified lipidated relaxin b chain peptides and their therapeutic use".

Company Profile

6.8.14

Ingenito; Raffaele - Pomezia IT
INGENITO; Raffaele - Pomezia RM
Ingenito; Raffaele - Rome IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
PCSK9 antagonists bicyclo-compounds Grant 11,306,125 - Xiong , et al. April 19, 2	2022-04-19
Modified Lipidated Relaxin B Chain Peptides And Their Therapeutic Use App 20210292387 - DUCLOS; Olivier ; et al.	2021-09-23
Cyclic Polypeptides For Pcsk9 Inhibition App 20210284694 - Ricardo; Alonso ; et al.	2021-09-16
Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Diseases App 20210261622 - Sun; Chengzao ; et al.	2021-08-26
Pcsk9 Antagonists Bicyclo-compounds App 20210214395 - Xiong; Yusheng ; et al.	2021-07-15
Cyclic Polypeptides For Pcsk9 Inhibition App 20210163538 - Ricardo; Alonso ; et al.	2021-06-03
Modified lipidated Relaxin B chain peptides and their therapeutic use Grant 10,988,523 - Brasseur , et al. April 27, 2	2021-04-27
Modified relaxin B chain peptides and their therapeutic use Grant 10,988,524 - Illiano , et al. April 27, 2	2021-04-27
Modified lipidated Relaxin B chain peptides and their therapeutic use Grant 10,961,295 - Duclos , et al. March 30, 2	2021-03-30
Modified Lipidated Relaxin B Chain Peptides And Their Therapeutic Use App 20190233493 - Brasseur; Denis ; et al.	2019-08-01
Modified Relaxin B Chain Peptides And Their Therapeutic Use App 20190233495 - ILLIANO; Stephane ; et al.	2019-08-01
Modified Lipidated Relaxin B Chain Peptides And Their Therapeutic Use App 20190233494 - DUCLOS; Olivier ; et al.	2019-08-01
Tricyclic derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) Grant 8,362,030 - Ingenito , et al. January 29, 2	2013-01-29
Heterocycle substituted ketone derivatives as histone deacetylase (HDAC) inhibitors Grant 8,026,265 - Jones , et al. September 27, 2	2011-09-27
Tricyclic Derivatives As Inhibitors Of Poly(adp-ribose) Polymerase (parp) App 20110053911 - Ingenito; Raffaele ; et al.	2011-03-03
Apoa-1 Peptide Mimetics App 20110046056 - Bianchi; Elisabetta ; et al.	2011-02-24
Heterocycle derivatives as histone deacetylase (HDAC) inhibitors Grant 7,863,294 - Attenni , et al. January 4, 2	2011-01-04
Heterocycle Substituted Ketone Derivatives as Histone Deacetylase (HDAC) Inhibitors App 20100234374 - Jones; Philip ; et al.	2010-09-16
Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors App 20090048228 - Attenni; Barbara ; et al.	2009-02-19
Amide Derivatives as Inhibitors of Histone Deacetylase App 20080262035 - Chakravarty; Prasun K. ; et al.	2008-10-23
Amide Derivatives as Inhibitors of Histone Deacetylase App 20080221157 - Chakravarty; Prasun K. ; et al.	2008-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.